INS and type 2 diabetes mellitus: The main pathogenesis of diabetes mellitus is insulin resistance and deficiency of insulin secretion.10,11 Currently, T2DM is treated clinically with a focus on ameliorating insulin function and promoting insulin secretion12, with hypoglycemic drugs being preferentially chosen to lower patients’ blood glucose.